Philogen S.p.a.
Clinical trials sponsored by Philogen S.p.a., explained in plain language.
-
New combo therapy aims to extend life in aggressive brain cancer
Disease control OngoingThis study tests a combination of two drugs, L19TNF and lomustine, in about 90 adults whose glioblastoma has come back or worsened. The goal is to find the best dose that is safe and may help people live longer. Participants will be monitored for side effects and survival over 12…
Phase: PHASE2 • Sponsor: Philogen S.p.A. • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Rheumatoid arthritis injection study halted before it began
Symptom relief TerminatedThis study aimed to test the safety of an experimental drug called F8IL10, given as a joint injection every 4 weeks for 8 weeks, in people with rheumatoid arthritis who still have flare-ups despite standard treatments. The study was withdrawn before any participants were enrolled…
Phase: PHASE1 • Sponsor: Philogen S.p.A. • Aim: Symptom relief
Last updated May 18, 2026 12:09 UTC